Condensed Consolidated Balance Sheets - USD ($)		Mar. 31, 2021		Dec. 31, 2020
ASSETS
Cash and cash equivalents	[1]	$ 11,717,804		$ 11,375,960
Restricted cash	[1]	32,154,188		57,999,396
Commercial mortgage loans held-for-investment, at amortized cost		484,165,249	[1]	547,345,334
Mortgage servicing rights, at fair value	[1]	899,223		919,678
Accrued interest receivable	[1]	2,173,007		2,015,617
Investment related receivable	[1]	34,539,187		0
Other assets	[1]	1,757,914		1,833,794
Total Assets	[1]	567,406,572		621,489,779
LIABILITIES:
Collateralized loan obligations, net	[1]	409,404,872		463,060,090
Secured term loan, net	[1]	39,598,532		39,556,198
Accrued interest payable	[1]	393,130		432,936
Dividends payable	[1]	2,248,612		3,242,640
Fees and expenses payable to Manager	[1]	1,204,688		1,156,340
Other accounts payable and accrued expenses	[1]	290,670		338,423
Total Liabilities	[1]	453,140,504		507,786,627
Commitments and contingencies	[1]
EQUITY:
Common Stock: par value $0.01 per share; 450,000,000 shares authorized, 24,943,383 shares issued and outstanding, at March 31, 2021 and December 31, 2020, respectively	[1]	249,389		249,389
Additional paid-in capital	[1]	233,853,156		233,850,271
Cumulative distributions to stockholders	[1]	(133,604,590)		(131,355,978)
Accumulated earnings	[1]	13,668,613		10,859,970
Total stockholders' equity	[1]	114,166,568		113,603,652
Noncontrolling interests	[1]	99,500		99,500
Total equity	[1]	114,266,068		113,703,152
Total liabilities and equity	[1]	$ 567,406,572		$ 621,489,779

[1] Our consolidated balance sheets include assets and liabilities of consolidated variable interest entities ("VIEs") as the Company was the primary beneficiary of these VIEs. As of March 31, 2021 and December 31, 2020, assets of consolidated VIEs related to Hunt CRE 2017-F1, Ltd. and Hunt CRE 2018-FL2, Ltd. totaled $537,399,673 and $591,318,506, respectively and the liabilities of consolidated VIEs related to Hunt CRE 2017-FL1, Ltd. and Hunt CRE 2018-FL2, Ltd totaled $409,716,943 and $463,411,967 respectively. See Note 4 for further discussion.